Global Heart Defect Closure Device Market Projected to Grow at 13.7% CAGR, Reaching $2.12 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Heart Defect Closure Device Industry Market Size Be by 2025?
Rapid growth has characterized the market size for heart defect closure devices in recent years. Forecasts show an increase from $1.11 billion in 2024 to $1.27 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.8%. Factors contributing to this growth during the historic period include the rising number of patients with congenital heart conditions, an aging population, heightened health consciousness, increased research and development, and improvements in catheterization procedures.

What's the Long-Term Growth Forecast for the Heart Defect Closure Device Market Size Through 2029?
The market for heart defect closure devices is anticipated to surge remarkably in the coming years, reaching $2.12 billion in 2029, at a compound annual growth rate (CAGR) of 13.7%. This predicted growth for the forecast period is linked to factors such as an increase in congenital defects, advancements in diagnostic methods, a higher demand for MRI procedures, an increased application of 3d imaging in heart defect closure operations, and a higher incidence of ischemic strokes. The period is also expected to see predominant trends such as technological progress, creation of new and innovative products, the design of next-generation heart closure devices, escalated detection of PFO closure devices, and the necessity to establish the advantages of PFO closure for the elderly.

View the full report here:
https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report

What Are the Key Growth Drivers Fueling the Heart Defect Closure Device Market Expansion?
An upsurge in individuals with innate heart anomalies is projected to accelerate the expansion of the heart defect closure device sector. Congenital heart issues are characterized as the inherent structural abnormalities of the heart. This spike in cases can be attributed to genetics, environmental factors, and health issues during pregnancy such as diabetes, obesity, and exposure to particular medications or infections. Heart defect closure devices provide a less invasive alternative to seal off irregular heart openings, thereby reinstating regular blood circulation, lessening complications, and enhancing overall heart functionality. For example, research in the National Library of Medicine (NLM), a US-based institution renowned for biomedical informatics and computational health data science, published an article in October 2024 stating a sharp increase to 5.46% in the incidence rate of CHD in 2023, contrasting with previous years: 1.12% in 2020, 2.36% in 2021, and 3.87% in 2022. Therefore, the escalating number of congenital heart defect cases is stimulating growth in the heart defect closure device market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16074&type=smp

What Long-Term Trends Will Define the Future of the Heart Defect Closure Device Market?
Key participants in the heart defect closure device market are focusing on the creation of self-expanding, double-disc occluders that offer a less invasive alternative for heart defect sealing. These devices heighten procedural safety, enhance patient results through shortened recovery periods, and reduce the probability of complications that arise from conventional open-heart surgeries. For example, Abbott Laboratories, a medical devices and healthcare firm based in the US, revealed the Amplatzer Talisman PFO Occlusion System in Europe in September 2022. This system, tasked with the closure of a patent foramen ovale (PFO), an unusual gap between the heart's left and right atria capable of causing strokes and other issues, employs a less invasive technique to release a self-expanding, double-disc occluder made from nitinol wire mesh. This effectively seals the PFO and blocks clot movement between the atria.

How Is the Heart Defect Closure Device Market Segmented?
The heart defect closure device market covered in this report is segmented -

1) By Type: Atrial Septal Defect (ASD) Closure Device, Left Atrial Appendage (LAA) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices
2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials
3) By Mode Of Delivery: Transcatheter Delivery, Surgical Delivery, Other Modes
4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Atrial Septal Defect (ASD) Closure Device: Occluder Devices (Septal Occluders), Implantable Patch Devices, Self-Expanding Devices, Balloon-Expandable Devices
2) By Left Atrial Appendage (LAA) Closure Devices: Occluder Devices (WATCHMAN Device), Clip-Based Devices, Self-Expanding LAA Closure Devices
3) By Patent Foramen Ovale (PFO) Closure Devices: Septal Occluders, Self-Expanding Occluders, Balloon-Expandable Occluders
4) By Patent Ductus Arteriosus (PDA) Closure Devices: Coil-Based Closure Devices, Stent-Based Closure Devices, Amplatzer Occluders
5) By Ventricular Septal Defect (VSD) Closure Devices: Septal Occluder Devices, Balloon-Expandable Occluders, Self-Expanding Occluders

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16074&type=smp

Which Companies Are Leading the Charge in Heart Defect Closure Device Market Innovation?
Major companies operating in the heart defect closure device market are Abbott Laboratories, Medtronic, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences, W L Gore and Associates, B. Braun, BIOTRONIK SE & Co. KG, Lepu Medical Technology, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, AtriCure Inc., LifeTech Scientific Corporation, Baylis Medical Company Inc., Biosense Webster Inc., Sahajanand Medical Technologies Limited, Occlutech, Cohere*x Medical Inc., Cardia Inc., Acrostak Corporation, Vivasure Medical, Transmural Systems Inc., Cormatrix Cardiovascular Inc., and St. Jude Medical LLC.

Which Regions Are Leading the Global Heart Defect Closure Device Market in Revenue?
North America was the largest region in the heart defect closure device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart defect closure device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16074

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.